Paxman AB (publ) (PAX.ST)

SEK 75.6

(-1.05%)

Operating Expenses Summary of Paxman AB (publ)

  • Paxman AB (publ)'s latest annual operating expenses in 2023 was 133.8 Million SEK , up 30.31% from previous year.
  • Paxman AB (publ)'s latest quarterly operating expenses in 2024 Q2 was 34.1 Million SEK , up 3.08% from previous quarter.
  • Paxman AB (publ) reported a annual operating expenses of 102.67 Million SEK in annual operating expenses 2022, up 36.71% from previous year.
  • Paxman AB (publ) reported a annual operating expenses of 75.1 Million SEK in annual operating expenses 2021, up 20.4% from previous year.
  • Paxman AB (publ) reported a quarterly operating expenses of 33.08 Million SEK for 2024 Q1, down -8.47% from previous quarter.
  • Paxman AB (publ) reported a quarterly operating expenses of 33.81 Million SEK for 2023 Q3, up 3.87% from previous quarter.

Annual Operating Expenses Chart of Paxman AB (publ) (2023 - 2017)

Created with Highcharts 11.1.0YearsOperating Expenses201720182019202020212022202325000000 SEK50000000 SEK75000000 SEK100000000 SEK125000000 SEK150000000 SEK

Historical Annual Operating Expenses of Paxman AB (publ) (2023 - 2017)

Year Operating Expenses Operating Expenses Growth
2023 133.8 Million SEK 30.31%
2022 102.67 Million SEK 36.71%
2021 75.1 Million SEK 20.4%
2020 62.37 Million SEK -4.52%
2019 65.33 Million SEK 29.99%
2018 50.25 Million SEK 56.54%
2017 32.1 Million SEK 0.0%

Peer Operating Expenses Comparison of Paxman AB (publ)

Name Operating Expenses Operating Expenses Difference
Acarix AB (publ) 82.85 Million SEK -61.497%
ADDvise Group AB (publ) 611.8 Million SEK 78.13%
ADDvise Group AB (publ) 611.8 Million SEK 78.13%
Arcoma AB 53.25 Million SEK -151.258%
Bactiguard Holding AB (publ) 4.96 Million SEK -2592.695%
BICO Group AB (publ) 2.84 Billion SEK 95.303%
Boule Diagnostics AB (publ) 210.44 Million SEK 36.42%
CellaVision AB (publ) 295.99 Million SEK 54.796%
Clinical Laserthermia Systems AB (publ) 68.93 Million SEK -94.11%
Chordate Medical Holding AB (publ) 1.3 Million SEK -10120.114%
C-Rad AB (publ) 3.8 Million SEK -3421.053%
Duearity AB (publ) 21.58 Million SEK -519.875%
Dignitana AB (publ) 74.73 Million SEK -79.03%
Episurf Medical AB (publ) 2.7 Million SEK -4855.556%
Getinge AB (publ) 10.75 Billion SEK 98.756%
Scandinavian Real Heart AB (Publ) 18.22 Million SEK -634.013%
Iconovo AB (publ) 63.35 Million SEK -111.193%
Integrum AB (publ) 90.57 Million SEK -47.729%
Luxbright AB (publ) 23.09 Million SEK -479.459%
Mentice AB (publ) 237.06 Million SEK 43.559%
OssDsign AB (publ) 175.6 Million SEK 23.805%
Promimic AB (publ) 48.55 Million SEK -175.581%
Qlife Holding AB (publ) 162.38 Million SEK 17.603%
SciBase Holding AB (publ) 69.97 Million SEK -91.208%
ScandiDos AB (publ) 61.03 Million SEK -119.208%
Sectra AB (publ) 39.06 Million SEK -242.524%
Sedana Medical AB (publ) 174.52 Million SEK 23.336%
Senzime AB (publ) 141.51 Million SEK 5.453%
SpectraCure AB (publ) 12.12 Million SEK -1003.232%
Stille AB 87.21 Million SEK -53.407%
Vitrolife AB (publ) 5.56 Billion SEK 97.597%
Xvivo Perfusion AB (publ) 440.92 Million SEK 69.655%